Galectin Therapeutics (GALT) Adds to Recent Speculative Gains

September 22, 2016 8:19 AM EDT Send to a Friend
Galectin Therapeutics (NASDAQ: GALT) adds to recent gains amid NASH stock takeover speculation following Allergen's (NYSE ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login